Center for the Study of Tobacco Products
Center for the Study of Tobacco Products
批准号:
10245298
负责人:
Alison Breland
金额:
$418.46万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-30 至 2023-08-31
关键词:
AbstinenceAddressAerosolsBehaviorBiometryCharacteristicsClinicalDataData SourcesDependenceDevelopmentDevicesElectronic cigaretteEngineeringEnsureEpidemiologistEuropean UnionEvaluationFinancial SupportFutureGenerationsHealthHealth PolicyHealth PromotionInhalationKnowledgeLeadLiquid substanceMeasuresMechanicsMethodologyMethodsModelingNicotineOutcomePilot ProjectsPopulationPostdoctoral FellowProcessPsychologistPublic HealthPublicationsRegulationResearch MethodologyRespiratory Signs and SymptomsScientistShapesSymptomsTestingTimeTobaccoTobacco useToxic effectUnited States National Institutes of HealthVisionWorkaddictionanalytical methodbasebehavioral economicscareercigarette smokingcohortconcept mappinge-cigarette aerosolselectronic cigarette useliquid nicotinenicotine exposurenovelpre-doctoralpredictive modelingpublic policy on tobaccotobacco productstobacco regulationtobacco regulatory sciencetobacco usertooltoxicant
中文摘要
项目总结。烟草制品研究中心(CSTP)开发了一个模型
英文摘要
Project Summary. The Center for the Study of Tobacco Products (CSTP) has developed a model for
evaluating novel tobacco products using, as exemplars, electronic cigarettes (ECIGs) that heat a liquid that
often contains nicotine, forming an aerosol that users inhale. Now, CSTP leverages its methodological and
ECIG expertise to pivot from product evaluation to an integrative theme of impact analysis. FDA tobacco
regulation must protect public health, though regulations may also have unintended consequences that cause
harm. For example, limiting ECIG liquid nicotine content, as in the European Union, can drive use of higher
power ECIGs that aerosolize more liquid, leading users to inhale more nicotine and other toxicants. Other
potential ECIG regulations involve constraining amount of nicotine emitted/unit time (nicotine “flux”) that may
influence product toxicity and abuse liability, or reducing flavor availability that may lead users to mix their own
flavored liquids. If FDA could predict a potential regulation’s effects, then refinements before the regulation is
issued might maximize its health-promoting effects and minimize unintended consequences. Methods exist for
assessing a regulation’s effects once it is in place, but few data-driven models predict impact beforehand. Any
such model must draw from several domains to assess how a potential regulation might change product
toxicity, user behavior, and addiction/abuse liability. Also, the model must demonstrate the extent to which
predictions about potential regulatory effects describe actual population-level outcomes. CSTP addresses this
issue with this application: Projects 1-3 will test hypotheses and generate predictions regarding the impact of
three potential ECIG regulations (i.e., limit nicotine, constrain flux, reduce flavor availability); Project 4 will test
these predictions at the population level. CSTP’s vision is to provide tools to guide regulation development so
that, by the time a regulation goes into effect, validated methods have tested it, refined it, and generated data
showing that its health-promoting effects are maximized and unintended consequences minimized.
The team (Drs. Eissenberg, Breland, Shihadeh, Cobb, Barnes, Cohen, Fagan) will complete 4 integrated
projects that aim to: predict product toxicity, predict user behavior, predict abuse liability, and assess potential
regulation impact. A Contextual Knowledge Core uses mixed methods to ensure Projects 1-4 reflect the real
world. A Career Enhancement Core conducts a tobacco regulatory science course, supports pre- and post-
doctoral appointees, and pilot projects. An Administrative Core supports financial/managerial processes,
biostatistical needs, receives input from an External Advisory Board, and interfaces with FDA, NIH, and others.
Overall, CSTP’s integrative theme of impact analysis draws on the team’s expertise in tobacco product toxicity,
user behavior, and abuse liability. We seek to provide FDA with hypothesis-driven data regarding advanced
generation ECIGs and test predictions about some potential regulations now, while developing a model that
can be used to shape, refine, and predict the effects of many potential regulatory actions in the future.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Career Enhancement Core
-
批准号:10477277
-
项目类别:
-
资助金额:$67.69万
-
财政年份:2013
-
负责人:Alison Breland
-
依托单位:
Project 2: Using user behavior data collected in the clinical lab to test hypotheses about advanced-generation ECIGs and generate population-level predictions regarding potential regulatory action
-
批准号:10245301
-
项目类别:
-
资助金额:$60.61万
-
财政年份:2013
-
负责人:Alison Breland
-
依托单位:
Project 2: Using user behavior data collected in the clinical lab to test hypotheses about advanced-generation ECIGs and generate population-level predictions regarding potential regulatory action
-
批准号:10477271
-
项目类别:
-
资助金额:$60.7万
-
财政年份:2013
-
负责人:Alison Breland
-
依托单位:
Center for the Study of Tobacco Products
-
批准号:10064198
-
项目类别:
-
资助金额:$15.49万
-
财政年份:2013
-
负责人:Alison Breland
-
依托单位:
Center for the Study of Tobacco Products
-
批准号:10477267
-
项目类别:
-
资助金额:$417.18万
-
财政年份:2013
-
负责人:Alison Breland
-
依托单位:
Career Enhancement Core
-
批准号:10245304
-
项目类别:
-
资助金额:$72.03万
-
财政年份:2013
-
负责人:Alison Breland
-
依托单位:
海外基金